Financhill
Back

Penumbra Vs. Protalix BioTherapeutics Industry Stock Comparison

Buy
58

PEN
Penumbra

Last Price:
205.62
Seasonality Move:
4.94%
Sell
36

PLX
Protalix BioTherapeutics

Last Price:
1.21
Seasonality Move:
3.5%
Buy
58
Penumbra (PEN) is a Buy

Is Penumbra a Buy, Sell or Hold?

  • The current Penumbra [PEN] share price is $203.00. The Score for PEN is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
  • PEN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
36
Protalix BioTherapeutics (PLX) is a Sell

Is Protalix BioTherapeutics a Buy, Sell or Hold?

  • The current Protalix BioTherapeutics [PLX] share price is $1.18. The Score for PLX is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • PLX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PEN Stock Price Chart

What is Penumbra's stock price today?

  • The Penumbra share price today is $203.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PEN is experiencing slight selling pressure.

PLX Stock Price Chart

What is Protalix BioTherapeutics's stock price today?

  • The Protalix BioTherapeutics share price today is $1.18
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PLX is experiencing buying pressure, which is a positive indicator for future bullish movement.

PEN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -7.93 Sell
Relative Strength Index (14 RSI): 32.99 Sell
Chaikin Money Flow: -72662 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (209.36 - 228.74) Sell
Bollinger Bands (100): (221.98 - 258.16) Sell

PLX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.06 Sell
Relative Strength Index (14 RSI): 41.93 Sell
Chaikin Money Flow: 225065 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.17 - 1.29) Sell
Bollinger Bands (100): (1.29 - 1.67) Sell

PEN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 209.55 Sell
20-day SMA: 215.71 Sell
50-day SMA: 234.18 Sell
200-day SMA: 244.58 Sell
8-day EMA: 208.26 Sell
20-day EMA: 215.92 Sell
50-day EMA: 227.64 Sell
200-day EMA: 241.78 Sell

PLX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.16 Buy
20-day SMA: 1.21 Sell
50-day SMA: 1.36 Sell
200-day SMA: 1.58 Sell
8-day EMA: 1.17 Buy
20-day EMA: 1.22 Sell
50-day EMA: 1.33 Sell
200-day EMA: 1.54 Sell

Penumbra Earnings Growth & PEN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.40 per share, a decrease next quarter of $0.11 per share, an increase this year of $0.79 per share, and an increase next year of $1.02 per share.

Protalix BioTherapeutics Earnings Growth & PLX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Penumbra Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Protalix BioTherapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):